Chemung Financial Corp. (CHMG)
NASDAQFinancialsBanks - RegionalSnapshot 2026-09-09
$83.90-0.63%
Close 2026-09-09 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-09-09
Intact: The reason to own it still holds.
Chemung Financial grows net income from $6.0M to $9.2M in one year. Operating income rose from $7.7M to $11.8M. Cash from operations increased from $7.2M to $9.0M. Dividends per share rose from $0.32 to $0.34, showing steady shareholder returns.
Revenue is expected to decline about 1% next year. Earnings estimates have recently been cut. Profit growth may stall, pressuring dividends and cash flow.
The price sits about 4% below our fair value near $78. Analysts expect about -1% revenue growth, which aligns with our view. We see potential upside if profitability and cash flow continue improving.
Breaks if: cash from operations falls below $9.0M in any quarter after 2026-Q1
Maintain and grow cash generated from operating activities to support financial flexibility and growth.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a moderate-risk opportunity in the financial sector. The current thesis state is watchful, as recent performance has improved, but there are concerns about execution quality and market expectations.
The market currently prices CHMG at a premium compared to its peers, indicating that investors have high expectations. However, the valuation is considered justified, suggesting that while it is expensive, the fundamentals are somewhat aligned with these expectations.
Management is focused on maintaining and growing net income and operating income, which have shown slight quarter-to-quarter variation. Cash from operating activities is on track for modest growth, and dividend payouts have increased, reflecting a commitment to shareholder returns.
The thesis hinges on the performance of sector bellwethers like HDB, IBN, and PNC. If these companies continue to perform well, it could support CHMG's growth. Conversely, any negative guidance from these peers could adversely affect CHMG's outlook.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no current threats to the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. Cash from operating activities was $9.0 million in 2026-Q1 and increased slightly to $9.2 million in 2026-Q2. Management links balance sheet repositioning to improved financial flexibility. The trajectory is delivering with modest growth.
“Balance sheet repositioning enhances balance sheet flexibility and positions organization for long-term success.”
“Record quarterly earnings validate strategic initiatives including balance sheet repositioning.”
Breaks if: dividend per share falls below $0.34 in any quarter after 2026-Q1
Sustain and grow quarterly dividend payments to shareholders as part of capital allocation strategy.
Stated as a priority in 3 disclosures including 2026-Q2 and two press releases in 2026. Quarterly dividend was $0.34 per share in 2026-Q2 and increased to $0.36 per share as of August 2026, a 5.9% increase. Management has consistently communicated dividend growth, showing delivering on this priority.
“Dividends declared during the second quarter of 2026 were $0.34 per share.”
Breaks if: net income falls below $9.2M in any quarter after 2026-Q1
Continue to increase net income and operating income through strategic initiatives and disciplined execution.
Stated as a priority in 2 of last 2 quarters. Net income was $9.2 million in 2026-Q1 and $8.8 million in 2026-Q2, with operating income of $11.8 million and $11.3 million respectively. Management highlights positive trajectory and strategic initiatives supporting earnings power. The trajectory shows delivering with slight quarter-to-quarter variation.
“Positive trajectory of operating results demonstrates effectiveness of actions to enhance earnings power.”
“Record quarterly earnings validate strategic initiatives including balance sheet repositioning and market entrance.”
Breaks if: operating income falls below $11.8M in any quarter after 2026-Q1
Continue to increase net income and operating income through strategic initiatives and disciplined execution.
Stated as a priority in 2 of last 2 quarters. Net income was $9.2 million in 2026-Q1 and $8.8 million in 2026-Q2, with operating income of $11.8 million and $11.3 million respectively. Management highlights positive trajectory and strategic initiatives supporting earnings power. The trajectory shows delivering with slight quarter-to-quarter variation.
“Positive trajectory of operating results demonstrates effectiveness of actions to enhance earnings power.”
“Record quarterly earnings validate strategic initiatives including balance sheet repositioning and market entrance.”
Over the next 1 to 3 years, CHMG's performance will depend on both internal execution and external sector dynamics. Not investment advice.